| **SEGMENT RESULTS (Reportable Segment Information ) (Details) - USD ($) $ in Millions**                                          | 3 Months Ended | 6 Months Ended | 12 Months Ended | 18 Months Ended |
|----------------------------------------------------------------------------------------------------------------------------------|----------------|----------------|-----------------|-----------------|
||
| **Segment Reporting Information [Line Items]**                                                                                   |           |           |            |            |   |   |
| Net sales                                                                                                                        | $ 1,990        | $ 1,715        | $ 3,376         | $ 3,455         |   |   |
| Interest income                                                                                                                  | 7              | 3              | 17              | 5               |   |   |
| Interest expense                                                                                                                 | (26)           | (23)           | (47)            | (45)            |   |   |
| Pension settlement charge                                                                                                        | (171)          | 0              | (171)           | 0               |   |   |
| Cyberattack costs                                                                                                                | (25)           | 0              | (49)            | 0               |   |   |
| Streamlined operating model                                                                                                      | (3)            | (4)            | (3)             | (23)            | $ (60) | $ (63) |
| Digital capabilities and productivity enhancements investment                                                                    | (32)           | (25)           | (59)            | (45)            |   |   |
| Earnings before income taxes                                                                                                     | $ 136          | $ 130          | $ 165           | $ 246           |   |   |
| Cyberattack | Product Concentration Risk                                                                                         |           |           |            |            |   |   |
| **Segment Reporting Information [Line Items]**                                                                                   |           |           |            |            |   |   |
| Concentration percentage                                                                                                         | 100.00%        |           | 100.00%         |            |   |   |
| Restructuring and Related Costs | Product Concentration Risk | Employee-Related Costs                                            |           |           |            |            |   |   |
| **Segment Reporting Information [Line Items]**                                                                                   |           |           |            |            |   |   |
| Concentration percentage                                                                                                         | 100.00%        | 100.00%        | 100.00%         | 100.00%         |   | 100.00% |
| Operating Segments | Health and Wellness                                                                                         |           |           |            |            |   |   |
| **Segment Reporting Information [Line Items]**                                                                                   |           |           |            |            |   |   |
| Net sales                                                                                                                        | $ 720          | $ 577          | $ 1,224         | $ 1,234         |   |   |
| Segment adjusted EBIT                                                                                                            | $ 259          | $ 124          | $ 363           | $ 257           |   |   |
| Operating Segments | Health and Wellness | Cyberattack | Product Concentration Risk                                              |           |           |            |            |   |   |
| **Segment Reporting Information [Line Items]**                                                                                   |           |           |            |            |   |   |
| Concentration percentage                                                                                                         | 9.00%          |           | 15.00%          |            |   |   |
| Operating Segments | Health and Wellness | Restructuring and Related Costs | Product Concentration Risk | Employee-Related Costs |           |           |            |            |   |   |
| **Segment Reporting Information [Line Items]**                                                                                   |           |           |            |            |   |   |
| Concentration percentage                                                                                                         | 0.00%          | 0.00%          | 0.00%           | 5.00%           |   | 6.00% |
| Operating Segments | Household                                                                                                   |           |           |            |            |   |   |
| **Segment Reporting Information [Line Items]**                                                                                   |           |           |            |            |   |   |
| Net sales                                                                                                                        | $ 502          | $ 462          | $ 827           | $ 885           |   |   |
| Segment adjusted EBIT                                                                                                            | $ 92           | $ 44           | $ 88            | $ 66            |   |   |
| Operating Segments | Household | Cyberattack | Product Concentration Risk                                                        |           |           |            |            |   |   |
| **Segment Reporting Information [Line Items]**                                                                                   |           |           |            |            |   |   |
| Concentration percentage                                                                                                         | 11.00%         |           | 11.00%          |            |   |   |
| Operating Segments | Household | Restructuring and Related Costs | Product Concentration Risk | Employee-Related Costs           |           |           |            |            |   |   |
| **Segment Reporting Information [Line Items]**                                                                                   |           |           |            |            |   |   |
| Concentration percentage                                                                                                         | 0.00%          | 0.00%          | 0.00%           | 0.00%           |   | 1.00% |
| Operating Segments | Lifestyle                                                                                                   |           |           |            |            |   |   |
| **Segment Reporting Information [Line Items]**                                                                                   |           |           |            |            |   |   |
| Net sales                                                                                                                        | $ 403          | $ 332          | $ 632           | $ 652           |   |   |
| Segment adjusted EBIT                                                                                                            | $ 109          | $ 74           | $ 128           | $ 134           |   |   |
| Operating Segments | Lifestyle | Cyberattack | Product Concentration Risk                                                        |           |           |            |            |   |   |
| **Segment Reporting Information [Line Items]**                                                                                   |           |           |            |            |   |   |
| Concentration percentage                                                                                                         | 12.00%         |           | 13.00%          |            |   |   |
| Operating Segments | Lifestyle | Restructuring and Related Costs | Product Concentration Risk | Employee-Related Costs           |           |           |            |            |   |   |
| **Segment Reporting Information [Line Items]**                                                                                   |           |           |            |            |   |   |
| Concentration percentage                                                                                                         | 0.00%          | 0.00%          | 0.00%           | 5.00%           |   | 3.00% |
| Operating Segments | International                                                                                               |           |           |            |            |   |   |
| **Segment Reporting Information [Line Items]**                                                                                   |           |           |            |            |   |   |
| Net sales                                                                                                                        | $ 311          | $ 286          | $ 581           | $ 571           |   |   |
| Segment adjusted EBIT                                                                                                            | $ 32           | $ 24           | $ 66            | $ 47            |   |   |
| Operating Segments | International | Cyberattack | Product Concentration Risk                                                    |           |           |            |            |   |   |
| **Segment Reporting Information [Line Items]**                                                                                   |           |           |            |            |   |   |
| Concentration percentage                                                                                                         | 7.00%          |           | 4.00%           |            |   |   |
| Operating Segments | International | Restructuring and Related Costs | Product Concentration Risk | Employee-Related Costs       |           |           |            |            |   |   |
| **Segment Reporting Information [Line Items]**                                                                                   |           |           |            |            |   |   |
| Concentration percentage                                                                                                         | 0.00%          | 0.00%          | 0.00%           | 16.00%          |   | 15.00% |
| Corporate and Other                                                                                                              |           |           |            |            |   |   |
| **Segment Reporting Information [Line Items]**                                                                                   |           |           |            |            |   |   |
| Net sales                                                                                                                        | $ 54           | $ 58           | $ 112           | $ 113           |   |   |
| Segment adjusted EBIT                                                                                                            | $ (106)        | $ (87)         | $ (168)         | $ (150)         |   |   |
| Corporate and Other | Cyberattack | Product Concentration Risk                                                                   |           |           |            |            |   |   |
| **Segment Reporting Information [Line Items]**                                                                                   |           |           |            |            |   |   |
| Concentration percentage                                                                                                         | 61.00%         |           | 57.00%          |            |   |   |
| Corporate and Other | Restructuring and Related Costs | Product Concentration Risk | Employee-Related Costs                      |           |           |            |            |   |   |
| **Segment Reporting Information [Line Items]**                                                                                   |           |           |            |            |   |   |
| Concentration percentage                                                                                                         | 100.00%        | 100.00%        | 100.00%         | 74.00%          |   | 75.00% |
| Operating Segments and Corporate and Other                                                                                       |           |           |            |            |   |   |
| **Segment Reporting Information [Line Items]**                                                                                   |           |           |            |            |   |   |
| Segment adjusted EBIT                                                                                                            | $ 386          | $ 179          | $ 477           | $ 354           |   |   |

| X                                                                                                                                                                                                                                                                                                    |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Digital Capabilities and Productivity Enhancements Expense
+ References
No definition available.
+ Details**Name:**clx_DigitalCapabilitiesAndProductivityEnhancementsExpense**Namespace Prefix:**clx_**Data Type:**xbrli:monetaryItemType**Balance Type:**debit**Period Type:**duration |
| X                                                                                                                                                                                                                              |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Segment Adjusted EBIT
+ References
No definition available.
+ Details**Name:**clx_SegmentAdjustedEBIT**Namespace Prefix:**clx_**Data Type:**xbrli:monetaryItemType**Balance Type:**credit**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20
+ Details**Name:**us-gaap_ConcentrationRiskPercentage1**Namespace Prefix:**us-gaap_**Data Type:**dtr-types:percentItemType**Balance Type:**na**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (h)(7) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(7) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 3A -Publisher FASB -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A
+ Details**Name:**us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**credit**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(11)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 235 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-05(b)(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 25 -Paragraph 1 -SubTopic 20 -Topic 940 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(10)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(15)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1
+ Details**Name:**us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**credit**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.9) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (210.5-03(11)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 835 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1
+ Details**Name:**us-gaap_InterestExpense**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**debit**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.7(a),(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2
+ Details**Name:**us-gaap_InvestmentIncomeInterestAndDividend**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**credit**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Amount of other expense that is infrequent in occurrence or unusual in nature.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483613/220-20-50-1
+ Details**Name:**us-gaap_OtherNonrecurringExpense**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**debit**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4(b)(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4(d)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1
+ Details**Name:**us-gaap_RestructuringAndRelatedCostIncurredCost**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**debit**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 924 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4
+ Details**Name:**us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**credit**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                            |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details**Name:**us-gaap_SegmentReportingInformationLineItems**Namespace Prefix:**us-gaap_**Data Type:**xbrli:stringItemType**Balance Type:**na**Period Type:**duration |
| X                                                                                                                                                      |
|--------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_ConcentrationRiskByBenchmarkAxis=clx_CyberattackMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                                  |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                                                |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_ConcentrationRiskByBenchmarkAxis=clx_RestructuringAndRelatedCostsBenchmarkMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                               |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                  |
|----------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                         |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                     |
|-------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                    |
|------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                                    |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**srt_ConsolidationItemsAxis=clx_OperatingSegmentsAndCorporateNonSegmentMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |